Andrew Davis

Analyst, Investment Banking at Back Bay Life Science Advisors

Andrew Davis is an experienced investment banking analyst currently working at Back Bay Life Science Advisors, focusing on life sciences M&A and strategic advisory. Previous roles include serving as an undergraduate researcher at the School of Biomedical Engineering at UBC, where a thesis was conducted in regenerative medicine and tissue engineering in Dr. Fabio Rossi’s lab, and as an investment banking summer analyst at Gravitas Securities Inc. Andrew also gained experience as a corporate development analyst for GenomeMe, a biotech startup, and as a scientific market researcher at Precision NanoSystems Inc., a leader in lipid nanoparticle genomic medicines. An academic background includes a Bachelor of Science and a Master of Management from The University of British Columbia, along with a high school diploma from Sentinel Secondary School and Collingwood School.

Location

Boston, United States

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Back Bay Life Science Advisors

Back Bay Life Science Advisors provides strategic guidance and investment banking to BioPharma and MedTech companies including product strategy, portfolio prioritization, and valuation.


Industries

Employees

11-50

Links